Uterine Artery Embolization and Future Fertility

2006 ◽  
Vol 17 (6) ◽  
pp. 1064-1065 ◽  
Author(s):  
Hyun S. Kim ◽  
Ajanta Patra
Keyword(s):  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Artery Embolization ◽  
Future Fertility

scholarly journals Cesarean Scar Pregnancy Treated by Artery Embolization Combined with Diode Laser: A Novel Approach for a Rare Disease

Medicina ◽  
2021 ◽  
Vol 57 (5) ◽  
pp. 411
Author(s):  
Felice Sorrentino ◽  
Vincenzo De Feo ◽  
Guglielmo Stabile ◽  
Raffaele Tinelli ◽  
Maurizio Nicola D’Alterio ◽  
...  
Keyword(s):  
Diode Laser ◽  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Artery Embolization ◽  
Artery Ligation ◽  
Cesarean Scar Pregnancy ◽  
Cesarean Scar ◽  
Dilation And Curettage ◽  
Management Protocol ◽  
Future Fertility

Cesarean scar pregnancy (CSP) is a rare form of ectopic pregnancy which represents a consequence of a previous cesarean section. It is associated with major maternal morbidity and mortality and has potential implications on future fertility. Because of possible serious complications, CSP should be swiftly diagnosed and treated. There is no management protocol for this rare, life-threatening condition, and each patient should be evaluated individually. Several types of conservative treatment have been used to treat cesarean scar pregnancy: dilation and curettage (D&C), excision of trophoblastic tissues, local or systemic administration of methotrexate, bilateral hypogastric artery ligation, and selective uterine artery embolization with curettage and/or methotrexate administration. In our study we present a cesarean scar pregnancy of a 40-year-old woman who was treated with angiographic uterine artery embolization (UAE) followed by hysteroscopic diode laser resection. Our combined UAE–hysteroscopic laser surgery appears to offer an effective, safe, and minimally invasive surgical treatment.

scholarly journals Successful Management of a Scary Case of Cesarean Scar Pregnancy with Combined Treatment using Methotrexate, Uterine Artery Embolization and Suction Evacuation

2015 ◽  
Vol 7 (3) ◽  
pp. 143-147
Author(s):  
Santhosh Joseph ◽  
Gonnabaktula Naga Vasanthalakshmi ◽  
Usha Vishwanath ◽  
M Anitha
Keyword(s):  
Uterine Rupture ◽  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Combined Treatment ◽  
Successful Management ◽  
Artery Embolization ◽  
Cesarean Scar Pregnancy ◽  
Cesarean Scar ◽  
Dilatation And Curettage ◽  
Future Fertility

ABSTRACT Cesarean scar pregnancy (CSP) is the rarest type of ectopic pregnancy implanted in the myometrium at the site of the previous cesarean section scar. It may lead catastrophic complications like uterine rupture and uncontrollable hemorrhage.4 Early diagnosis can offer treatment options of avoiding uterine rupture and hemorrhage, thus, preserving the uterus and future fertility. The conservative treatment can be by local and/or systemic administration of methotrexate, dilatation and curettage, excision of trophoblastic tissues (laparoscopy/laparotomy), bilateral internal artery ligation with trophoblastic evacuation and uterine artery embolization7 combined with curettage and/ or methotrexate. We did successful treatment of a viable CSP by systemic injections of methotrexate followed by selective uterine artery embolization in combination with dilatation and curettage. How to cite this article Mehta P, Vishwanath U, Joseph S, Anitha M. Successful Management of a Scary Case of Cesarean Scar Pregnancy with Combined Treatment using Methotrexate, Uterine Artery Embolization and Suction Evacuation. J South Asian Feder Obst Gynae 2015;7(3):143-147.

scholarly journals Cervical ectopic pregnancy

2021 ◽  
Vol 5 (06) ◽  
pp. 01-03
Author(s):  
Olivia Dziadek ◽  
Asha Bhalwal ◽  
Ramesha Papanna ◽  
Kenneth Moise ◽  
John Hardy ◽  
...  
Keyword(s):  
Minimally Invasive ◽  
Ectopic Pregnancy ◽  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Minimally Invasive Approach ◽  
Artery Embolization ◽  
Invasive Approach ◽  
Dilation And Curettage ◽  
Future Fertility ◽  
Cervical Ectopic Pregnancy

We performed dilation and curettage and cervical balloon placement in a cervical ectopic pregnancy after treatment with Methotrexate, KCI and bilateral uterine artery embolization. A minimally invasive approach was used in the case as the patient desired future fertility. We present the potential challenges in management of cervical ectopic pregnancy as well as approaches to treatment.

Three-dimensional power Doppler assessment of pelvic structures after unilateral uterine artery embolization for postpartum hemorrhage

2012 ◽  
Vol 1 (1-2) ◽  
Author(s):  
Thomas G. Tullius ◽  
Jason Robert Ross ◽  
Akwugo Eziefule ◽  
Melhem Ghaleb ◽  
Sanja Kupesic Plavsic
Keyword(s):  
Postpartum Hemorrhage ◽  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Doppler Ultrasonography ◽  
Power Doppler ◽  
Local Treatment ◽  
Three Dimensional ◽  
Power Doppler Ultrasonography ◽  
Artery Embolization ◽  
Future Fertility

AbstractDelayed postpartum hemorrhage, defined as bleeding following delivery up to 6 weeks postpartum, is a risk following cesarean or vaginal delivery. Episodes most commonly occur between 8 and 14 days postpartum. Here, we present a case of a 24-year-old woman presenting with delayed postpartum hemorrhage 14 days after delivery, which later proved to be caused by left uterine artery hemorrhage. The hemorrhage was refractory to local treatment and required invasive measures to prevent hypotensive shock. In lieu of a hysterectomy, a unilateral uterine artery embolization (UAE) was performed to preserve fertility in this 24-year-old patient. Three-dimensional power Doppler ultrasonography was performed 3 weeks after UAE to assess the volume and vascularity of the pelvic structures. This case illustrates a viable intervention for women with postpartum hemorrhage who desire to preserve future fertility, as well as a method to detect structural and vascular changes after the treatment to evaluate their future fertility prospects.

Uterine Artery Embolization Combined with Dilation and Curettage for the Treatment of Cesarean Scar Pregnancy: Efficacy and Future Fertility

2018 ◽  
Vol 41 (8) ◽  
pp. 1165-1173 ◽  
Author(s):  
Amartuvshin Tumenjargal ◽  
Hiroyuki Tokue ◽  
Hiroshi Kishi ◽  
Hiromi Hirasawa ◽  
Ayako Taketomi-Takahashi ◽  
...  
Keyword(s):  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Artery Embolization ◽  
Cesarean Scar Pregnancy ◽  
Cesarean Scar ◽  
Dilation And Curettage ◽  
Future Fertility

scholarly journals Uterine Artery Embolization and Future Fertility Potential

2007 ◽  
Vol 3 (4) ◽  
pp. 449-453
Author(s):  
Kee Jiet Ong ◽  
Mostafa Metwally ◽  
William L Ledger
Keyword(s):  
Pregnancy Outcome ◽  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Adverse Pregnancy Outcome ◽  
Case Reports ◽  
Artery Embolization ◽  
Safety And Efficacy ◽  
Future Fertility ◽  
Adverse Pregnancy

The growing body of evidence concerning the safety and efficacy of uterine artery embolization (UAE) has led to increasing confidence amongst gynecologists and interventional radiologists that UAE can be used safely to treat women with symptomatic fibroids. UAE is clearly preferable for certain subgroups of patients, for example those with increased risks of complications of general anesthesia, those with religious objection to blood transfusion and those wishing to avoid surgical risk. This review of the available literature demonstrates the paucity of information concerning safety and efficacy of UAE for those wishing to conceive. Case reports and series are largely positive. However, there are continuing concerns over the effects of UAE on ovarian and uterine function, and on subsequent pregnancy outcome. More long-term data and randomized controlled trials are required to address these issues. Women who undergo embolization should be told that the effects on pregnancy and the resulting child are uncertain and that there may be long-term implications for the health and development of the offspring. Hence, it is inadvisable to try to conceive following the procedure. Given the available evidence, concern must remain that UAE may lead to significant damage to fertility, with higher risk of miscarriage and adverse pregnancy outcome when compared with open or laparoscopic myomectomy.

scholarly journals Successful medical management of uterine arteriovenous malformation

2021 ◽  
Vol 10 (6) ◽  
pp. 2519
Author(s):  
Aparajita Rastogi ◽  
Neetu Kumari ◽  
Sarita Rajbhar ◽  
Pushpawati Thakur ◽  
Sagarika Majumdar
Keyword(s):  
Side Effects ◽  
Arteriovenous Malformation ◽  
Gnrh Agonist ◽  
Medical Management ◽  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Reproductive Age ◽  
Artery Embolization ◽  
Future Fertility ◽  
Uterine Arteriovenous Malformation

Uterine Arteriovenous malformation (AVM) is defined as abnormal communication between the uterine arteries and veins. This can be congenital or acquired. It occurs more frequently in reproductive age group women. Patient present with complain of spotting per vagina to catastrophic bleeding per vaginum. Diagnosis is based upon clinical history and findings in colour doppler of pelvis. The treatment depends upon the age of the patient, her symptoms, age, desire of future fertility and localization and size of the lesion. Uterine artery embolization is the most commonly used treatment for symptomatic uterine arteriovenous malformation. There were few case reports of successful medical management of uterine AVM with GnRH agonist. But GnRH agonist have side effects that restrict its long time use and for Uterine artery embolization, clinical skill and set up is required and it is not available at every hospital. Here is presenting a case report of successful medical management of uterine arteriovenous malformation with combined oral contraceptive pills (coc). COC are easily available everywhere and its side effects are few if compared with GnRH agonist.

scholarly journals A Comparison of Transvaginal Removal and Repair of Uterine Defect for Type II Cesarean Scar Pregnancy and Uterine Artery Embolization Combined With Curettage

2021 ◽  
Vol 8 ◽  
Author(s):  
Shanshan Cao ◽  
Guijing Qiu ◽  
Peipei Zhang ◽  
Xinyan Wang ◽  
Qing Wu
Keyword(s):  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Treatment Method ◽  
Complication Rates ◽  
Type Ii ◽  
Success Rates ◽  
Artery Embolization ◽  
Cesarean Scar Pregnancy ◽  
Cesarean Scar ◽  
Future Fertility

Background: There is no consensus on a standardized therapy for type II cesarean scar pregnancy (CSP II). The objective of the present study was to evaluate the efficacy and safety and compare costs associated with transvaginal removal and repair (TRR) of uterine defect for CSP II to those of uterine artery embolization (UAE) and curettage.Methods: We conducted a retrospective study that included 87 patients diagnosed with CSP II and treated by performing UAE in combination with curettage and hysteroscopy (n = 53), or TRR (n = 34). Clinical data and outcomes were analyzed.Results: UAE and TRR groups exhibited similar success rates. The TRR group had significantly lower complication rates (30.19 vs. 8.82%, P < 0.05) and lower total costs (13,765.89 ± 2,029.12 vs. 9,063.82 ± 954.67, P < 0.05) than the UAE group. The anterior myometrium of the lower uterine segment was relatively thicker after performing TRR, and no patient suffered from recurrent CSP II. The proportion of patients in the TRR group who had full-term delivery without uterine rupture was 88.24% (30/34), while four patients failed to pregnancy.Conclusion: TRR is a safe and effective treatment method for patients with CSP II and presents a highly cost-effective outcome, especially for patients with future fertility desire.

Sign in / Sign up

Export Citation Format

Share Document